Cost-effectiveness of primary cytology a
β
Peter Bistoletti; Karin SennfΓ€lt; Joakim Dillner
π
Article
π
2007
π
John Wiley and Sons
π
French
β 93 KB
## Abstract Because costβeffectiveness of different cervical cytology screening strategies with and without human papillomavirus (HPV) DNA testing is unclear, we used a Markov model to estimate life expectancy and health care cost per woman during the remaining lifetime for 4 screening strategies: